Prevenar 13

Prevenar 13 Indications/Uses

vaccine, pneumococcal

Manufacturer:

Pfizer

Distributor:

Pfizer
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Pneumococcal Conjugate Vaccine, 13-valent (adsorbed) (Prevenar 13) is indicated for the prevention of invasive disease, pneumonia, and otitis media caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants, children and adolescents.
For adults aged 18 years and older, Pneumococcal Conjugate Vaccine, 13-valent (adsorbed) (Prevenar 13) is indicated for the prevention of pneumococcal disease (including pneumonia and invasive disease) caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in